Invus Public Equities Advisors, LLC
SEC-identified person · CIK 1340096 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Scholar Rock Holding Corp SRRK | Officer | filed 2018 - 2024 |
| Glycomimetics INC GLYC | Officer | filed 2023 - 2024 |
| Lexicon Pharmaceuticals, INC./DE LXRX | Director | filed 2007 - 2024 |
| Omega Therapeutics, Inc. OMGA | Officer | filed 2021 - 2021 |
| Seer, Inc. SEER | Officer | filed 2020 - 2021 |
| SQZ Biotechnologies Co SQZ | Officer | filed 2020 - 2020 |
| Generation Bio Co. GBIO | Officer | filed 2020 - 2020 |
| Furiex Pharmaceuticals, Inc. FURX | Director | filed 2013 - 2013 |
| Nitromed INC NTMD | Officer | filed 2008 - 2009 |
| Antigenics INC /DE/ agend | Officer | filed 2008 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.